Tirzepatide denied as non-formulary by Cigna?

Cigna's specific coverage criteria for tirzepatide are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denies Tirzepatide as Non-Formulary

A non-formulary denial means tirzepatide is not included on Cigna's covered drug list for your specific plan, or it is placed at a tier that your benefit design does not cover. Formulary decisions are plan-level, not clinical — this denial is not a statement that tirzepatide is ineffective or inappropriate. It is a coverage-design decision, and it is subject to a formulary exception process when clinical need is documented.

Cigna must have a formulary exception process under most state and federal regulations. A formulary exception allows coverage of a non-formulary drug when a covered formulary alternative is clinically inappropriate for the specific patient.

## Your Federal Appeal Rights

Under ACA §2719 and ERISA §503, non-formulary denials are subject to internal appeal and independent external review. You typically have 180 days from the denial to file an internal appeal. External review is available for approximately 4 months after final internal denial. Request expedited review if your condition is urgent.

## Concrete Appeal Steps

1. Confirm the denial basis: request the specific formulary tier or exclusion reason in writing. 2. Request Cigna's formulary exception criteria for tirzepatide — what must be shown for a covered-drug alternative to be considered inadequate. 3. Identify the formulary alternative(s) Cigna would cover — your prescriber must address each one specifically. 4. Have your prescriber document why each covered formulary alternative is clinically inappropriate for this patient (prior failure, contraindication, documented intolerance, or distinct clinical need). 5. File a formulary exception request as the first step; if denied, file a formal internal appeal. 6. If internally denied, proceed to external review.

## Documentation to Gather

• List of Cigna-covered alternatives for the relevant indication (obtainable from Cigna's published formulary)
• Prior treatment records: dates, agents, durations, documented outcomes for each covered alternative already tried
• Prescriber letter addressing each formulary alternative: explains why each is inadequate for this specific patient
• Diagnosis and severity documentation: establishes clinical stakes and the importance of the specific drug
• Adverse event or intolerance records: if prior formulary alternatives caused documented adverse effects

## Criteria-Mapping Structure

For each formulary alternative Cigna identifies, the prescriber's letter should state: (1) whether it was tried — if yes, the date, duration, and documented outcome; (2) if not tried, the clinical reason (contraindication, likely intolerance, distinct mechanism needed). Submit this as a structured list. Formulary exceptions are granted most reliably when every alternative is addressed and none are left without a clinical reason for exclusion.